- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Innovative Clinical Research Inc Cerritos, California, United States
- Baptist MD Anderson Jacksonville, Florida, United States
- Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Indiana, United States
- Norton Healthcare Louisville, Kentucky, United States
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
2,608 public trials
494 recruiting studies
Multiple Myeloma trial results
NCT07614243
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chemotherapy-induced Peripheral Neuropathy, +18 more
- Locations
-
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) Hangzhou, Zhejiang, China
NCT03106324
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Innsbruck University Hospital Innsbruck, Austria
- LKH Hochsteiermark Leoben, Austria
- University hospital St. Pölten Pölten, Austria
- CHU Saint-Pierre Brussels, Belgium
NCT04640779
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +24 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT05032820
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford Hospital and Clinics Palo Alto, California, United States
- University of California, San Francisco San Francisco, California, United States
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
NCT05831787
- Conditions
- Blood Protein Disorders, COVID-19, Cardiovascular Diseases, +24 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
- UNC-Chapel Hill Chapel Hill, North Carolina, United States
NCT01053949
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- CHRU-Hôpital Sud, avenue Laennec, Amiens, France
- Hématologie, Hôpital Avicenne Bobigny, France
- Hématologie, CHU, avenue G.Clemenceau Caen, France
- Hématologie Clinique, CHU, Hôpital d'Enfants Dijon, France
Completed
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
NCT02362035
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Denver, Colorado, United States
- Research Site Washington D.C., District of Columbia, United States
NCT04093596
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- City of Hope Duarte, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- Sarah Cannon/Colorado Blood Cancer Institute Denver, Colorado, United States
NCT01009840
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
- Loyola University Medical Center Maywood, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States